GLP-1 Price Check
A seller quotes you a monthly figure and you have nothing to set it against. This places it among 363 published prices — every seller on this site that publishes one, with any membership or program fee already added in and any four-week term already converted to a calendar month.
Against 146 published prices for semaglutide, injection
$249 a month is higher than 84% of them. The median is $179, and the published range runs $76 to $408.
118 published prices are lower. Against the median you would pay $840 more across a year.
What this number is not
- Cheaper is not better. Some of the lowest figures here are microdoses, which are a smaller dose rather than a discount on the same product, and some are opening prices that rise at the next step of the ladder.
- Every figure is all-in as far as we can establish it. Where a seller charges a membership or a program fee outside its headline, we add it before ranking. Your quote may not be on the same basis — check what it excludes before comparing.
- A month must be a month. Several sellers price a four-week supply and print it with a monthly symbol. Thirteen of those land in a year, not twelve.
- These are advertised prices, not walked checkouts. They are what each seller publishes, corrected for fees and terms — not what a completed purchase charged.
Every published price, lowest first · Turn a headline into a true monthly figure · How these prices are recorded
Why a median is more useful here than a lowest price
Injectable semaglutide runs from $76 to $408 a month across 146 sellers, and the median sits at $179. A spread that wide on one molecule is not a quality gradient — the cheapest and the dearest are frequently the same compounded preparation from similar pharmacies. It is a spread in what sellers think they can charge.
That is why the floor is a poor benchmark. Chasing it leads to microdose products priced against other sellers’ standard doses, and to opening rates that step up as you titrate. The median tells you whether a quote is inside the market at all, which is the question a reader actually has. What a year actually costs carries the arithmetic across twelve months, and the flat-pricing board covers the sellers whose figure does not move as the dose does.
Every price here is what a seller publishes, corrected — not a walked checkout. That distinction is the whole discipline of this site and it is set out in the methodology. Most of these products are compounded, which means they are not FDA-approved and are not reviewed by the FDA for safety, efficacy or quality before they are dispensed; price says nothing about which preparation is which.